How the EU decides to regulate CRISPR gene-edited crops will have ‘huge impact’ on US, rest of world

gmo action

Most gene editing techniques should not come under the Europe Unionโ€™s strict regulatory regime for genetically modified organisms, according to a preliminary legal opinion.

The opinion by an โ€œadvocate generalโ€ of the European Court of Justice isnโ€™t a binding legal decision, but itโ€™s considered highly persuasive for the panel of judges who will issue a ruling on the matter this summer.

Advocates of biotechnology see the opinion as an early step in the right direction regarding Europeโ€™s gene editing policy, but critics say itโ€™s unlikely to sway wary European consumers.

For U.S. agriculture, Europeโ€™s approach to gene editing is significant because the technology is expected to become more widely commercialized among American farmers in coming years.

Already, the USDA has cleared numerous gene-edited crops for the market without subjecting them to the environmental review required under the deregulatory process for GMOs.

Apart from affecting exports of such crops to the European Union, the continentโ€™s biotech policies have a โ€œhuge impactโ€ on other global regions, particularly in the developing world, said Mary Boote, CEO of the Global Farmer Network, which supports gene editing.

โ€œIts importance is felt well beyond the borders of Europe,โ€ Boote said.

Read full, original post:ย Legal opinion: Gene editing exempt from Europeโ€™s GMO rules

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDAโ€™s expedited drug reviews are hailed in some quarters but other approval practices are problematic
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challengingย 
Farmers can talk to plants
Farmers are a major source of misinformationโ€”about farming
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
What explains Homo sapiensโ€™ huge brains? Ancient climate change played a role
Viewpoint: Internal White House documents detail administrationโ€™s strategy to undermine climate science
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint โ€” Food-fear world: The latest activist scientists campaign: Cancer-causing additives
ChatGPT-Image-May-7-2026-11_28_04-AM-2
โ€˜Conflict entrepreneursโ€™ are driving disinformation and shaping public opinion
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Screenshot 2026-05-06 at 2.19
Vaccine shootout at the CDCย 
ChatGPT-Image-May-6-2026-03_41_05-PM
โ€˜Protecting the integrity of scienceโ€™: Kennedyโ€™s FDA blocks release of taxpayer-funded studies finding COVID and shingles vaccines safe
Screenshot-2026-05-06-at-2.07.43-PM
Manufacturing a conspiracy: The timeline of howย  the White House embraced the fringe claim that scientists are being mysteriously murdered
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.